Tissue expression
Cell line expression
Protein structure

ATIC

5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
AICARFT, IMPCHASE, PURH 
This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009]
More gene data

All Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antigen sequence

Epitope

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
437 antibodies from 36 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Atlas Antibodies
1 antibody
Invitrogen Antibodies
24 antibodies
Proteintech Group
1 antibody
GeneTex
5 antibodies
antibodies-online
123 antibodies
OriGene
17 antibodies
Novus Biologicals
38 antibodies
Aviva Systems Biology
5 antibodies
Bioworld Technology, Inc
2 antibodies
Biorbyt
26 antibodies
Cusabio Biotech Co., Ltd
8 antibodies
Abnova Corporation
7 antibodies
NovoPro Bioscience Inc.
3 antibodies
Affinity Biosciences
1 antibody
Wuhan Fine Biotech Co., Ltd.
1 antibody
Acris Antibodies GmbH
3 antibodies
Signalway Antibody LLC
1 antibody
Bethyl Laboratories
2 antibodies
ProSci
4 antibodies
RabMAbs
2 antibodies
Exalpha Biologicals, Inc.
1 antibody
St John's Laboratory
3 antibodies
Creative Biolabs
13 antibodies
Arigo
1 antibody
BioLegend
1 antibody
United States Biological
37 antibodies
Boster Biological Technology
2 antibodies
MyBioSource
6 antibodies
Abbexa
9 antibodies
Creative Diagnostics
6 antibodies
RayBiotech, Inc.
2 antibodies
MilliporeSigma / Merck KGaA
4 antibodies
Leading Biology
2 antibodies
Abgent
1 antibody